If you suffered a stroke, heart attack or another serious cardiovascular event after taking a “Low T” prescription testosterone treatment, don’t hesitate in pursuing an AndroGel lawsuit. A number of cases already filed over this product allege that it was aggressively marketed as a therapy for fatigue, low libido and other symptoms associated with aging, and to patients with normal levels of testosterone. AndroGel is just one of several medications that have come under scrutiny following recent studies that lend evidence to their association with cardiovascular side effects.
If you were prescribed AndroGel or another prescription medication and experienced a heart attack, stroke, deep vein thrombosis, pulmonary embolism or another side effect, you may be entitled to compensation for out-of-pocket medical expenses, lost wages, and other damages incurred by your injuries.
The attorneys at Bernstein Liebhard LLP are actively evaluating potential testosterone treatment lawsuits from individuals who may have been injured as a result of taking AndroGel, Androderm, Axiron, Bio-T-Gel, Testopel and other medications.
Filing an AndroGel lawsuit may earn you compensation for damages caused by this prescription testosterone treatment therapy, which has been promoted by its manufacturer as being the most popular in its class, and one of the most effective in raising low T levels.
According to AndroGel’s website, AndroGel 1.62% contains the “the same testosterone” as what is normally produced by the body, and is the leading topical replacement therapy, as of September 2012.
Also included on AndroGel’s homepage are the results of a clinical study that found testosterone levels returned to normal in 82% of patients who took AndroGel 1.62% once daily for 16 weeks, and in 37% of those who used a placebo. The research included 274 men with low testosterone levels, according to the site, which also describes the gel as clear, odorless, quick-drying and effective in raising your T levels.
In January 2014, the U.S. Food and Drug Administration (FDA) announced its safety review of AndroGel and other testosterone treatment therapies after several studies suggested that use of the medications may result in heart attacks, strokes and other near-fatal cardiovascular events. That same month, for example, the findings of research in the medical journal PLoS One revealed that men younger than 65 who had a history of heart disease, and older men without heart problems may be at an increased risk for cardiovascular problems allegedly caused by AndroGel and other Low T treatments.
Data from 410,019 US men and 6,858 men in the UK who had begun testosterone therapy was factored into this research, which also found the two groups to be at a doubled risk for testosterone heart attacks in the first 90 days.
Since the FDA’s Drug Safety Communication, which stressed that a concrete connection between AndroGel and the risk for strokes, heart attacks and other injuries had not been confirmed, court documents indicate that four AndroGel lawsuits had been filed on behalf of men who allege the above side effects.
Men who may have been injured after taking prescription Low T therapies may be eligible to file AndroGel lawsuit claims. Contact an attorney at Bernstein Liebhard LLP to seek compensation for damages that may have been caused by one of the above testosterone treatment therapies, and to ensure that your legal rights are protected. Call us today at .